Implementing an Oncology Decision Support System: The Case of the Brazilian National Cancer Institute.


Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
04 Jul 2019
Historique:
entrez: 27 7 2019
pubmed: 28 7 2019
medline: 3 9 2019
Statut: ppublish

Résumé

Brazil has a complex situation in cancer treatment services. The incidence rates have reached around 600.000 new cases each year. The development of an Oncology Decision Support System (ODSS) that support cancer treatment is amongst the priorities in the cancer control program. The purpose of this article is to study the ODSS deployment at the Brazilian National Cancer Institute. The implementation of this Clinical Decision Support System employed on the management, processing, and analysis of Brazilian cancer clinical data can be considered a disruptive innovation which changes the clinical decision-making process radically.

Identifiants

pubmed: 31349259
pii: SHTI190010
doi: 10.3233/SHTI190010
doi:

Types de publication

Journal Article

Langues

eng

Pagination

35-38

Auteurs

Antônio Augusto Gonçalves (AA)

Instituto Nacional de Câncer - COAE Tecnologia da Informação, Rio de Janeiro, Brazil.
Universidade Estácio de Sá - MADE, Rio de Janeiro, Brazil.

Sandro Luís Freire de Castro Silva (SLF)

Instituto Nacional de Câncer - COAE Tecnologia da Informação, Rio de Janeiro, Brazil.

Roberto Luiz Silva Santos (RL)

Instituto Nacional de Câncer - COAE Tecnologia da Informação, Rio de Janeiro, Brazil.

Cezar Cheng (C)

Instituto Nacional de Câncer - COAE Tecnologia da Informação, Rio de Janeiro, Brazil.

José Geraldo Pereira Barbosa (JG)

Universidade Estácio de Sá - MADE, Rio de Janeiro, Brazil.

Carlos Henrique Fernandes Martins (CHF)

Instituto Nacional de Câncer - COAE Tecnologia da Informação, Rio de Janeiro, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH